financetom
Business
financetom
/
Business
/
Lululemon Athletica Rangebound Amid Growth Slowdown, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lululemon Athletica Rangebound Amid Growth Slowdown, UBS Says
Sep 1, 2024 2:32 AM

03:53 PM EDT, 08/30/2024 (MT Newswires) -- Lululemon Athletica ( LULU ) Q2 Americas sales growth was 1% year over year, raising concerns about whether this slowdown is temporary or indicative of a longer-term trend, UBS said in a note Friday.

The company expects to restart historic product innovation by spring 2025, which might keep it rangebound until that time, the investment firm said.

Lululemon reported Q2 earnings of $3.15 a share, which was slightly above consensus estimates, with total revenues growing 7.3% year over year to $2.37 billion, UBS said.

While US sales remain under pressure, Lululemon's international regions, particularly Mainland China, showed strong momentum, and can drive a 32% year-over-year increase in international sales for Q3, it added.

UBS maintained a neutral rating and $315 price target for Lululemon.

Price: 258.38, Change: -0.63, Percent Change: -0.24

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arrowhead Pharmaceuticals to Receive $200 Million Payment From Sarepta Therapeutics for Meeting ARO-DM1 Milestone
Arrowhead Pharmaceuticals to Receive $200 Million Payment From Sarepta Therapeutics for Meeting ARO-DM1 Milestone
Nov 24, 2025
08:13 AM EST, 11/24/2025 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Monday that it has earned a $200 million milestone payment from Sarepta Therapeutics ( SRPT ) for meeting a second development milestone event in a phase 1/2 clinical study of ARO-DM1 to treat type 1 myotonic dystrophy. Under the terms of the license and collaboration deal between...
X-energy raises $700 million to expand nuclear reactor projects in US
X-energy raises $700 million to expand nuclear reactor projects in US
Nov 24, 2025
Nov 24 (Reuters) - Nuclear reactor developer X-energy said on Monday it had closed a $700 million financing round led by trading company Jane Street to help expand its supply chain and commercial pipeline. WHY IT'S IMPORTANT The U.S. nuclear industry is undergoing a renaissance after years of stagnation, primarily driven by surging power demand from the so-called hyperscalers that...
Veeva Systems Expands Partnership With Roche Pharmaceuticals
Veeva Systems Expands Partnership With Roche Pharmaceuticals
Nov 24, 2025
08:12 AM EST, 11/24/2025 (MT Newswires) -- Veeva Systems ( VEEV ) said Monday that Roche Pharmaceuticals has extended its partnership with the company by integrating Veeva Vault CRM, a deep application for life sciences. Financial terms of the expanded partnership were not disclosed. The Vault CRM platform includes Veeva AI, which features industry-specific AI agents, including Free Text Agent,...
Trubar Q3 Revenue Jumps 88%
Trubar Q3 Revenue Jumps 88%
Nov 24, 2025
08:13 AM EST, 11/24/2025 (MT Newswires) -- Trubar ( TRBRF ) said Monday that third-quarter net revenue and adjusted EBITDA both advanced. The company, which manufactures plant-based protein products, said net revenue jumped 88% to US$21.6 million. Adjusted EBITDA rose to $1.4 million from the $1 million in the previous corresponding quarter. Trubar ( TRBRF ) reaffirmed its full year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved